Cerity Partners Portfolio holdings
AUM
$56.1B
This Quarter Return
+5.11%
1 Year Return
+16.67%
3 Year Return
+60.49%
5 Year Return
+100.94%
10 Year Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$956M
Cap. Flow
% of AUM
22.7%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$113M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$47.5M |
| 3 |
Apple
AAPL
|
$43.3M |
| 4 |
Microsoft
MSFT
|
$37.8M |
| 5 |
Amazon
AMZN
|
$32.4M |
Top Sells
| 1 |
CMD
Cantel Medical Corporation
CMD
|
$15.9M |
| 2 |
Caterpillar
CAT
|
$9.08M |
| 3 |
Golub Capital BDC
GBDC
|
$7.49M |
| 4 |
Intel
INTC
|
$7.26M |
| 5 |
iShares Biotechnology ETF
IBB
|
$5.89M |
Sector Composition
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
651
DELISTED
Diebold Nixdorf Incorporated
DBD
| $209K | 0.01% |
14,780
-2,500
| -14% | -$35.4K |
|
652
Cardlytics
CDLX
$47.2M
| $208K | ﹤0.01% |
1,900
-400
| -17% | -$43.8K |
|
653
lululemon athletica
LULU
$24B
| $208K | ﹤0.01% |
679
-7
| -1% | -$2.14K |
|
654
PACCAR
PCAR
$50.6B
| $207K | ﹤0.01% |
+3,339
| New | +$207K |
|
655
Brookfield
BN
$98.1B
| $206K | ﹤0.01% |
+5,776
| New | +$206K |
|
656
Spotify
SPOT
$144B
| $206K | ﹤0.01% |
+770
| New | +$206K |
|
657
SPDR S&P Regional Banking ETF
KRE
$4B
| $205K | ﹤0.01% |
+3,093
| New | +$205K |
|
658
Bank of New York Mellon
BK
$74.4B
| $204K | ﹤0.01% |
+4,321
| New | +$204K |
|
659
FirstEnergy
FE
$25.3B
| $204K | ﹤0.01% |
+5,895
| New | +$204K |
|
660
McKesson
MCK
$86.1B
| $203K | ﹤0.01% |
1,043
-939
| -47% | -$183K |
|
661
Xcel Energy
XEL
$43.3B
| $203K | ﹤0.01% |
3,055
-1,439
| -32% | -$95.6K |
|
|
AMED
662
DELISTED
Amedisys
AMED
| $202K | ﹤0.01% |
+763
| New | +$202K |
|
663
Diageo
DEO
$61.3B
| $202K | ﹤0.01% |
+1,229
| New | +$202K |
|
664
HEICO
HEI
$44.6B
| $200K | ﹤0.01% |
+1,593
| New | +$200K |
|
665
West Pharmaceutical
WST
$17.8B
| $200K | ﹤0.01% |
+711
| New | +$200K |
|
666
Global Net Lease
GNL
$1.76B
| $196K | ﹤0.01% |
10,870
-1,644
| -13% | -$29.6K |
|
667
UroGen Pharma
URGN
$892M
| $196K | ﹤0.01% |
+10,041
| New | +$196K |
|
668
ProShares Short S&P500
SH
$1.25B
| $188K | ﹤0.01% |
2,803
| – | – |
|
|
HFRO
669
Highland Opportunities and Income Fund
HFRO
$342M
| $186K | ﹤0.01% |
+16,805
| New | +$186K |
|
|
BPMP
670
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $177K | ﹤0.01% |
14,000
+2,000
| +17% | +$25.3K |
|
671
Stagwell
STGW
$1.48B
| $173K | ﹤0.01% |
55,500
| – | – |
|
672
America Movil
AMX
$58.8B
| $157K | ﹤0.01% |
11,551
+311
| +3% | +$4.23K |
|
673
Cerus
CERS
$247M
| $150K | ﹤0.01% |
+25,000
| New | +$150K |
|
|
KLDO
674
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $150K | ﹤0.01% |
+18,500
| New | +$150K |
|
|
PTVE
675
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $137K | ﹤0.01% |
10,000
| – | – |
|